These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 8225153

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Management strategies for the treatment of schizophrenia.
    Kane JM.
    J Clin Psychiatry; 1999; 60 Suppl 12():13-7. PubMed ID: 10372604
    [Abstract] [Full Text] [Related]

  • 23. Clozapine treatment after agranulocytosis induced by classic neuroleptics.
    Bauer M, Mackert A.
    J Clin Psychopharmacol; 1994 Feb; 14(1):71-3. PubMed ID: 7908676
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Improved efficacy and fewer side effects under clozapine treatment after addition of fluvoxamine.
    Szegedi A, Wiesner J, Hiemke C.
    J Clin Psychopharmacol; 1995 Apr; 15(2):141-3. PubMed ID: 7782489
    [No Abstract] [Full Text] [Related]

  • 28. Combination antipsychotics: pros, cons, and questions.
    Miller AL, Craig CS.
    Schizophr Bull; 2002 Apr; 28(1):105-9. PubMed ID: 12047009
    [Abstract] [Full Text] [Related]

  • 29. Blood Draw Barriers for Treatment with Clozapine and Development of a Point-of-Care Monitoring Device.
    Kelly DL, Ben-Yoav H, Payne GF, Winkler TE, Chocron SE, Kim E, Kitchen C, Stock V, Vyas G, Love RC, Wehring HJ, Sullivan KM, Feldman S, Liu F, McMahon RP, Ghodssi R.
    Clin Schizophr Relat Psychoses; 2018 Apr; 12(1):23-30. PubMed ID: 26218235
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Subjective muscle weakness and hypotonia during clozapine treatment.
    Galletly C.
    Ann Clin Psychiatry; 1996 Dec; 8(4):189-92. PubMed ID: 8986312
    [Abstract] [Full Text] [Related]

  • 32. Interaction between caffeine and clozapine.
    Vainer JL, Chouinard G.
    J Clin Psychopharmacol; 1994 Aug; 14(4):284-5. PubMed ID: 7962690
    [No Abstract] [Full Text] [Related]

  • 33. Seizure with low doses of clozapine.
    More J.
    Am J Psychiatry; 1992 Oct; 149(10):1413-4. PubMed ID: 1530089
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Strong Treatment Response and High Maintenance Rates of Clozapine in Childhood-Onset Schizophrenia.
    Kasoff LI, Ahn K, Gochman P, Broadnax DD, Rapoport JL.
    J Child Adolesc Psychopharmacol; 2016 Jun; 26(5):428-35. PubMed ID: 26784704
    [Abstract] [Full Text] [Related]

  • 36. Safety and effectiveness of low-dose clozapine in psychogeriatric patients: a preliminary study.
    Oberholzer AF, Hendriksen C, Monsch AU, Heierli B, Stähelin HB.
    Int Psychogeriatr; 1992 Jun; 4(2):187-95. PubMed ID: 1477306
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Clozapine: a novel antipsychotic agent.
    Bablenis E, Weber SS, Wagner RL.
    DICP; 1989 Feb; 23(2):109-15. PubMed ID: 2658370
    [Abstract] [Full Text] [Related]

  • 39. Fluorescence of neutrophil granulocytes as a biomarker for clozapine use.
    Man WH, Ten Berg M, Wilting I, Huisman A, Cahn W, Douma JW, den Breeijen H, Heerdink ER, Egberts T, van Solinge W.
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1408-13. PubMed ID: 24074821
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.